摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-{3,5-dimethylfuro[3,2-g]coumarin-6-yl}-N-[(pyridin-3-yl)methyl]propanamide

中文名称
——
中文别名
——
英文名称
3-{3,5-dimethylfuro[3,2-g]coumarin-6-yl}-N-[(pyridin-3-yl)methyl]propanamide
英文别名
3-(3,5-dimethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)-N-(pyridin-3-ylmethyl)propanamide;3-(3,5-dimethyl-7-oxofuro[3,2-g]chromen-6-yl)-N-(pyridin-3-ylmethyl)propanamide
3-{3,5-dimethylfuro[3,2-g]coumarin-6-yl}-N-[(pyridin-3-yl)methyl]propanamide化学式
CAS
——
化学式
C22H20N2O4
mdl
——
分子量
376.412
InChiKey
CBSJZQRMHLBRLC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    28
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    81.4
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    Novel furocoumarins as potential HIV-1 integrase inhibitors
    摘要:
    A series of seven novel, rationally designed N-substituted 3-{3,5-dimethylfuro[3,2-g] coumarin-6-yl} propanamides have been prepared as potential HIV-1 integrase (IN) inhibitors via a five-step pathway commencing with resorcinol and diethyl 2-acetylglutarate, and the HIV-1 IN inhibition potential of these compounds has been examined relative to raltegravir, a known HIV-1 IN inhibitor. (C) 2014 Published by Elsevier Inc.
    DOI:
    10.1016/j.bioorg.2014.07.008
点击查看最新优质反应信息

文献信息

  • Novel furocoumarins as potential HIV-1 integrase inhibitors
    作者:Temitope O. Olomola、Salerwe Mosebi、Rosalyn Klein、Telisha Traut-Johnstone、Judy Coates、Raymond Hewer、Perry T. Kaye
    DOI:10.1016/j.bioorg.2014.07.008
    日期:2014.12
    A series of seven novel, rationally designed N-substituted 3-3,5-dimethylfuro[3,2-g] coumarin-6-yl} propanamides have been prepared as potential HIV-1 integrase (IN) inhibitors via a five-step pathway commencing with resorcinol and diethyl 2-acetylglutarate, and the HIV-1 IN inhibition potential of these compounds has been examined relative to raltegravir, a known HIV-1 IN inhibitor. (C) 2014 Published by Elsevier Inc.
查看更多